本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aura Biosciences, Inc.

6.27
-0.2700-4.13%
盘后:6.270.00000.00%16:10 EDT
成交量:166.32万
成交额:1,051.50万
市值:6.48亿
市盈率:-3.54
高:6.56
开:6.53
低:6.18
收:6.54
52周最高:9.54
52周最低:4.73
股本:1.03亿
流通股本:7,464.31万
量比:1.81
换手率:2.23%
股息:- -
股息率:- -
每股收益(TTM):-1.7726
每股收益(LYR):-1.7599
净资产收益率:-53.49%
总资产收益率:-31.24%
市净率:2.06
市盈率(LYR):-3.56

数据加载中...

2025/05/16

重要事件披露

Form 8-K - Current report
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]